8570- UTI-CARE

Purpose and goal

Urinary tract infections (UTIs) are a common infection worldwide and a major driver of antibiotic overuse. Up to 60% of treatments are unnecessary due to slow diagnostics. Utilizer-AST, a PoC test, combines bacterial detection, by species ID and concentration with AST to deliver faster results without the need for specialists. By enabling timely, cost-efficient, evidence-based diagnostics, it reduces unnecessary antibiotics and improves outcomes. Ready for CE-IVDR submission at project end.

Expected effects and result

UTI-CARE delivers Utilizer-AST, a rapid PoC test that identifies 5 UTI pathogens and their potential antibiotic resistance. Easy to use and cost-effecient, the test enables same-day evidence-based treatment, reduces unnecessary antibiotic use, recurrent infections with additional healthcare costs, and supports the EU/UK target of reducing antibiotic use by 20–25% by 2030. Ready for CE-IVDR submission at project end.

Planned approach and implementation

Utilizer will coordinate the main partners Karolinska Institutet and M2 Automation. During the specification phase a KOL group from UK, NL and SE will work together with the project partners to set requirements for Utilizer-AST. Utilizer develop the test according to iterated specification in close corporation with M2 Automation. The MVP will be tested by a clinical group led by Karolinska Instititutet and results analysed and recorded in a technical file ready for CE-IVDR submission.